Karios Technologies is a UCSD-UCLA spinout company that has a novel, patented hydrogel platform that we are using first to prevent postsurgical adhesions with an initial focus on heart transplant patients and children with congenital heart defects.
The Texas Medical Device Alliance
Karios Technologies is a UCSD-UCLA spinout company that has a novel, patented hydrogel platform that we are using first to prevent postsurgical adhesions with an initial focus on heart transplant patients and children with congenital heart defects.